Phenergan: Effective Relief for Allergic Reactions and Nausea

Phenergan

Phenergan

Price from 42.00 $

Phenergan, known generically as promethazine, is a versatile prescription medication belonging to the class of phenothiazines. It is widely utilized for its potent antihistaminic, antiemetic, and sedative properties. This medication works by blocking histamine receptors in the body, thereby alleviating symptoms associated with allergies, motion sickness, and postoperative nausea. It is also employed as an adjunct to analgesics for its calming effects. Available in various formulations including tablets, syrup, and injectable solutions, Phenergan is a trusted option in both clinical and home settings under proper medical guidance.

Features

  • Contains promethazine hydrochloride as the active ingredient
  • Available in multiple formulations: tablets (12.5 mg, 25 mg, 50 mg), syrup (6.25 mg/5 mL), and injectable solution (25 mg/mL, 50 mg/mL)
  • Exhibits antihistaminic, antiemetic, sedative, and anticholinergic properties
  • Onset of action: oral forms typically within 20 minutes; IV/IM administration acts more rapidly
  • Half-life ranges from 9 to 16 hours, allowing for sustained symptom control

Benefits

  • Provides rapid and effective relief from allergic symptoms such as itching, hives, and runny nose
  • Significantly reduces nausea and vomiting associated with motion sickness, surgery, or illness
  • Induces sedation to aid in managing anxiety or promoting restful sleep when indicated
  • Can be used as an adjunct to pain medications to enhance their efficacy and provide comfort
  • Available in pediatric-strength formulations for age-appropriate dosing in children over 2 years of age
  • Offers flexible administration routes to accommodate patient needs and clinical scenarios

Common use

Phenergan is commonly prescribed for the management of allergic conditions, including seasonal allergies, allergic rhinitis, and cutaneous manifestations such as urticaria. It is also indicated for preventing and treating nausea and vomiting related to motion sickness, postoperative recovery, or radiation therapy. In some cases, it is used perioperatively for sedation and as an adjunct to analgesics. Off-label uses may include management of migraine-associated nausea, and as a short-term sleep aid due to its sedating effects. It is important that usage aligns with a healthcare provider’s recommendations based on individual patient assessment.

Dosage and direction

Dosage must be individualized based on the patient’s age, condition, severity of symptoms, and response to therapy.
Adults:

  • For allergies: 12.5 mg before bedtime or 6.25–12.5 mg three times daily.
  • For nausea/vomiting: 12.5–25 mg every 4–6 hours as needed.
  • For sedation: 25–50 mg at bedtime.

Children (≥2 years):
Dosing is weight-based and should not exceed adult recommendations. Typically, 0.25–0.5 mg/kg per dose every 6 hours, not to exceed 25 mg.

Phenergan may be administered orally (tablet or syrup), intramuscularly, or intravenously (with caution). Tablets should be taken with water; syrup should be measured with a dosing device. Do not crush or chew extended-release formulations. Avoid abrupt discontinuation.

Precautions

Phenergan may cause drowsiness, dizziness, or blurred vision. Patients should avoid driving or operating machinery until they know how the medication affects them. Alcohol and other CNS depressants should be avoided due to additive sedative effects. Use with caution in patients with respiratory conditions (e.g., asthma, COPD), cardiovascular disease, narrow-angle glaucoma, or prostatic hypertrophy. Elderly patients may be more sensitive to side effects, especially sedation and anticholinergic effects. Phenergan may mask symptoms of other serious conditions, such as intestinal obstruction or brain injury. Not recommended for children under 2 years due to risk of respiratory depression.

Contraindications

Phenergan is contraindicated in individuals with known hypersensitivity to promethazine or any component of the formulation. It should not be used in comatose patients, or in those with suspected or established subcortical brain damage. Avoid use in pediatric patients under 2 years of age. Contraindicated in patients with bone marrow suppression, severe liver impairment, or narrow-angle glaucoma. Do not administer intra-arterially or subcutaneously due to risk of severe tissue injury.

Possible side effect

Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, and constipation. Less frequently, patients may experience hypotension, tachycardia, extrapyramidal symptoms (e.g., restlessness, dystonia), or photosensitivity. Rare but serious adverse effects include neuroleptic malignant syndrome, agranulocytosis, seizures, and respiratory depression, especially in vulnerable populations. Injection site reactions (pain, necrosis) may occur with improper administration. Patients should seek medical attention if they experience difficulty breathing, severe dizziness, or signs of an allergic reaction.

Drug interaction

Phenergan has the potential to interact with numerous medications. Concomitant use with other CNS depressants (e.g., opioids, benzodiazepines, alcohol) can enhance sedation and respiratory depression. It may potentiate the effects of anticholinergic drugs. Monoamine oxidase inhibitors (MAOIs) can increase the risk of adverse effects and should be avoided. Phenergan may counteract the effects of dopamine agonists and epinephrine. Use with caution alongside drugs that prolong the QT interval. Always inform your healthcare provider of all medications, including over-the-counter products and supplements.

Missed dose

If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to catch up. Resume the regular dosing schedule. If unsure, contact a healthcare provider or pharmacist for guidance.

Overdose

Overdose of Phenergan can be life-threatening. Symptoms may include severe drowsiness, deep sleep, coma, seizures, respiratory depression, and cardiovascular collapse. In children, excitability and paradoxical reactions may occur. Treatment is supportive and may include airway management, activated charcoal (if ingestion was recent), and monitoring of vital signs. There is no specific antidote. In case of suspected overdose, seek immediate medical attention or contact a poison control center.

Storage

Store Phenergan at room temperature (15–30°C or 59–86°F), away from light, moisture, and heat. Keep the medication in its original container, tightly closed. Do not freeze the liquid formulation. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly discard any unused or expired medication according to local guidelines.

Disclaimer

This information is intended for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Do not disregard professional medical advice based on content herein. Individual responses to medication may vary. In case of a medical emergency, contact your local emergency services immediately.

Reviews

“Phenergan has been a reliable option for managing my severe motion sickness during long flights. It works quickly and allows me to travel comfortably.” – Sarah T., verified user
“As an allergist, I find Phenergan effective for acute allergic presentations, though I monitor for sedation in older patients.” – Dr. Evan R., healthcare professional
“Used postoperatively with caution, it significantly reduced nausea in my patients without excessive drowsiness when dosed appropriately.” – Nurse Julia L.
“The syrup formulation was easy to administer to my child for allergy relief, though I was cautious about dosing.” – Michael P., parent
“Effective but sedating—best taken at night for allergy symptoms.” – Linda K., long-term user